Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has introduced a new reporting solution as part of its ClinPhone Randomization and Trial Supply Management (RTSM) technologies, which offer validated randomization methods, automated inventory control, dispensing and titration management, and emergency code break capabilities. The reporting solution features a Universal Report Suite to monitor trial management performance, RTSM Dashboard with trending and forecasting functionalities, and Self-Service Module with customizable search criteria for power users who are focused on in-depth data analysis.
"Our customers are facing increasing complexity and globalization of their clinical studies, often resulting in significant timeline and supply pressures. To assist them, Perceptive Informatics offers sophisticated technologies supporting their requirements for more robust reporting and enabling faster strategic decision-making," said Todd Kole, Vice President, IVRS Business, Perceptive Informatics. "Our RTSM reporting solution has been designed to help monitor trial progress and provide efficient access to study data and metrics."
"We have incorporated extensive, valuable input from our clients as well as Perceptive's experience in providing automated randomization and trial supply management technologies for thousands of clinical trials into the development of this new feature-rich RTSM reporting solution," said Nikki Dowlman, Ph.D., Product Manager, Perceptive Informatics. "The solution offers powerful reporting functionalities for various trial management roles to help answer key questions through intelligent analysis and presentation of trial randomization and supply management data."
The new RTSM reporting solution features three modules:
- A Universal Report Suite, which offers a comprehensive collection of ready-made, validated reports that can be quickly configured for individual study needs. The reports provide key performance metrics, presenting an accurate snapshot of study progress including recruitment and trial supply status.
- An RTSM Dashboard, which provides high level metrics and forecasting data, including access to key performance indicators for analyzing trends to inform decision-making. Metrics include supplies utilization forecasting and production planning as well as recruitment forecasting and progress against targets.
- A Self-Service Module, which allows users to create and download their own tailored data sets from a live study database for performing complex or specialized analyses.
Perceptive's RTSM reporting solution is designed for optimal performance to allow quick and efficient access to study data and metrics through advanced functionalities. Its features include the ability to create and export graphs or charts containing key study data, and download data in a variety of formats including Microsoft Excel, Microsoft PowerPoint, PDF and Active HTML files. The solution also allows users to download and share reports for local display and data queries using a snapshot of the live database. Graphical displays of trends and forecasts in a user-friendly, interactive online format enable rapid information assimilation and enhanced data interpretation.
For more information about the capabilities of the ClinPhone RTSM reporting solution, visit: http://www.perceptive.com/ClinPhone-RTSM/RTSM-Reporting-Solution.html.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.